Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that it is now taking orders for the t:flex™ Insulin Pump, with shipments planned to begin in June. The 480-unit t:flex Pump, cleared by the U.S. Food and Drug Administration in January 2015, is the largest capacity insulin pump currently offered in the United States.
"Two-thirds of the healthcare providers we interviewed prior to developing the t:flex Pump cited limited capacity as the number one barrier to pump adoption for people with type 2 diabetes who use insulin," said Kim Blickenstaff, President and CEO of Tandem Diabetes Care. "We believe the t:flex Pump addresses an important unmet need in the diabetes community, with its 480-unit reservoir and 60-unit maximum bolus, and we are proud to offer this option for people with greater insulin needs."
The t:flex Pump is designed for people who require more than 80 units of U-100 insulin per day, such as teenagers with type 1 diabetes and many people with type 2 diabetes. For people with greater insulin needs, the pump offers the benefits of pump therapy without the frequent reservoir changes required by 200- and 300-unit pumps. It incorporates the same slim design, advanced Micro-Delivery® technology, and simple-to-use touch-screen interface as the t:slim Insulin Pump, rated #1 by pump users for two years in a row.
Study finds regular physical activity slows biological aging in type 2 diabetes patients